Your browser doesn't support javascript.
loading
Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial.
Raven, Lisa Mary; Muir, Christopher A; Kessler Iglesias, Cassia; Bart, Nicole K; Muthiah, Kavitha; Kotlyar, Eugene; Macdonald, Peter; Hayward, Christopher S; Jabbour, Andrew; Greenfield, Jerry R.
Afiliação
  • Raven LM; Department of Diabetes and Endocrinology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia lisa.raven@svha.org.au.
  • Muir CA; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Kessler Iglesias C; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Bart NK; Department of Diabetes and Endocrinology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
  • Muthiah K; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Kotlyar E; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Macdonald P; Department of Heart and Lung Transplantation, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
  • Hayward CS; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.
  • Jabbour A; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Greenfield JR; Department of Heart and Lung Transplantation, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
BMJ Open ; 13(3): e069641, 2023 03 29.
Article em En | MEDLINE | ID: mdl-36990488

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Ethics Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália